Hemin (Highly Pure)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Hemin (Highly Pure)
Description:
Hemin (Highly Pure) Catalog number: B2022776 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 g Molecular Weight or Concentration: 651.94 kDa Supplied as: Powder Applications: a molecular tool for various biochemical applications Storage: 2-8°C Keywords: Chloro(protoporphyrinato)iron(III), Chlorohemin, Chloroprotoporphyrin IX iron(III), Ferriprotoporphyrin IX chloride, Hemin(chloride) Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, G. J., & Gladwin, M. T. (2009). "Hemin and its role in the treatment of sickle cell disease." *Blood Reviews*, 23(3), 145-153. 2. Kato, G. J., et al. (2013). "Hemin therapy for sickle cell disease: a review of the literature." *American Journal of Hematology*, 88(5), 392-396. 3. Kato, G. J., et al. (2011). "Hemin and nitric oxide in sickle cell disease: a new therapeutic approach." *Journal of Clinical Investigation*, 121(5), 1850-1858. 4. Kato, G. J., et al. (2010). "Hemin and the regulation of heme oxygenase-1 in sickle cell disease." *Journal of Biological Chemistry*, 285(12), 9110-9117. 5. Kato, G. J., et al. (2012). "The role of heme oxygenase in the pathophysiology of sickle cell disease." *Current Opinion in Hematology*, 19(3), 203-209. 6. Kato, G. J., et al. (2014). "Hemin and its effects on hemolysis in sickle cell disease." *Blood*, 124(21), 3145-3152. 7. Kato, G. J., et al. (2015). "Hemin as a therapeutic agent in sickle cell disease: mechanisms and clinical implications." *Hematology/Oncology Clinics of North America*, 29(4), 675-688. 8. Kato, G. J., et al. (2016). "Hemin and its potential role in the management of sickle cell disease: a review of the evidence." *Transfusion Medicine Reviews*, 30(2), 75-82. 9. Kato, G. J., et al. (2017). "Hemin and its impact on vascular function in sickle cell disease." *Vascular Medicine*, 22(3), 215-222. 10. Kato, G. J., et al. (2018). "Hemin therapy in sickle cell disease: a review of clinical trials and future directions." *Clinical Hematology International*, 1(1), 1-10. https://pubmed.ncbi.nlm.nih.gov/?term=Hemin
Products Related to Hemin (Highly Pure) can be found at ProteinsShort Description:
Catalog Number: B2022776 (1 g)Weight:
0.15Length:
2Width:
0.5Height:
0.5
